Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples